AbCellera Biologics Inc. Contracts & Agreements
23 Contracts & Agreements
- Business Finance (5 contracts)
- Business Operations (2)
- Human Resources (8)
- Intellectual Property (4)
- Mergers & Acquisitions (1)
- Real Estate (1)
- Uncategorized (2)
- Separation Agreement and Release between AbCellera Biologics Inc. and Neil Berkley (Filed With SEC on July 19, 2022)
- Description of Securities (Filed With SEC on March 30, 2021)
- Form of Underwriting Agreement (Filed With SEC on December 7, 2020)
- Form of Specimen Common Share Certificate (Filed With SEC on December 7, 2020)
- Employment Agreement between the Registrant and Carl L. G. Hansen, Ph.D., dated August 1, 2019, as amended (Filed With SEC on December 7, 2020)
- Employment Agreement between the Registrant and Andrew Booth, dated April 12, 2019 (Filed With SEC on December 7, 2020)
- Employment Agreement between the Registrant and Tryn Stimart, dated July 10, 2019 (Filed With SEC on December 7, 2020)
- Employment Agreement between the Registrant and Vronique Lecault, Ph.D., dated December 20, 2016, as amended (Filed With SEC on December 7, 2020)
- Sixth Amended and Restated Stock Option Plan, and form of award agreement thereunder (Filed With SEC on December 7, 2020)
- 2020 Share Option and Incentive Plan, and forms of award agreements thereunder (Filed With SEC on December 7, 2020)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on December 7, 2020)
- 2020 Employee Share Purchase Plan (Filed With SEC on December 7, 2020)
- Executive Severance Plan (Filed With SEC on December 7, 2020)
- Form of Director and Officer Indemnification Agreement (Filed With SEC on December 7, 2020)
- Agreement and Plan of Merger among the Registrant, AbCellera US Holdings Inc., Mickey Merger Inc., Trianni, Inc. and Fortis Advisors LLC, dated November 1, 2020 (Filed With SEC on November 20, 2020)
- Amended and Restated Investors Rights Agreement among the Registrant and certain of its shareholders, dated March 23, 2020 (Filed With SEC on November 20, 2020)
- Lease between 0775021 BC Ltd. and the Registrant dated June 2, 2017, as amended (Filed With SEC on November 20, 2020)
- Research Collaboration and License Agreement between the Registrant and Eli Lilly and Company, dated March 11, 2020 (Filed With SEC on November 20, 2020)
- Patent License Agreement between the U.S. Department of Health and Human Services, as represented by National Institute of Allergy and Infectious Diseases and the Registrant,... (Filed With SEC on November 20, 2020)
- License Agreement between the Board of Trustees of the Leland Stanford Junior University and Lineage Biosciences Inc., dated February 11, 2015 (Filed With SEC on November 20, 2020)
- Amendment No. 1 to License Agreement between the Board of Trustees of the Leland Stanford Junior University and Lineage Biosciences Inc., dated March 22, 2017 (Filed With SEC on November 20, 2020)
- License Agreement between the University of British Columbia and the Registrant dated December 16, 2013 (Filed With SEC on November 20, 2020)
- Strategic Innovation Fund Agreement between the Registrant and her Majesty the Queen in right of Canada as represented by the Minister of Industry, dated April 11, 2020 (Filed With SEC on November 20, 2020)
